Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Elevance Health Community
NYSE:ELV Community
4
Narratives
written by author
0
Comments
on narratives written by author
167
Fair Values set
on narratives written by author
Community Investing Ideas
Elevance Health
Popular
Undervalued
Overvalued
Elevance Health
NA
NateF
Community Contributor
ELV Market Outlook
Elevance Health, Inc. (NYSE: ELV) is a prominent player in the health benefits industry, offering a range of services including medical, pharmaceutical, dental, and behavioral health plans.
View narrative
US$390.54
FV
18.9% undervalued
intrinsic discount
6.79%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
8 months ago
author updated this narrative
Elevance Health
AN
AnalystLowTarget
Consensus Narrative from 18 Analysts
ACA And Medicaid Will Squeeze Margins Though Tech Will Aid
Key Takeaways Elevated costs in government-backed plans and greater reliance on value-based care could compress margins despite operational improvements and diversification strategies. Increasing regulatory changes, political uncertainty, and provider sophistication in technology may erode pricing power and add to earnings volatility.
View narrative
US$297.00
FV
6.6% overvalued
intrinsic discount
6.26%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
Elevance Health
AN
AnalystHighTarget
Consensus Narrative from 18 Analysts
Aging Trends And Digital Integration Will Expand Managed Care Markets
Key Takeaways Value-based care and AI-driven efficiencies are improving cost predictability and margins, positioning Elevance for durable, above-peer earnings growth. Expanding Carelon and government segment revenues diversify growth, with disciplined capital allocation enhancing long-term returns and shareholder value.
View narrative
US$496.33
FV
36.2% undervalued
intrinsic discount
7.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Elevance Health
AN
AnalystConsensusTarget
Consensus Narrative from 18 Analysts
AI-Enabled Analytics And Value-Based Care Will Ensure Future Stability
Key Takeaways Technology investments in analytics, digitization, and AI are boosting efficiency, reducing costs, and improving margin stability across operations. Expansion into value-based care, behavioral health, and government programs supports revenue growth, earnings diversity, and long-term margin improvement.
View narrative
US$368.44
FV
14.1% undervalued
intrinsic discount
6.78%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
95
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
ELV
ELV
Elevance Health
Your Fair Value
US$
Current Price
US$316.55
11.7% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
257b
2015
2018
2021
2024
2025
2027
2030
Revenue US$256.7b
Earnings US$7.3b
Advanced
Set Fair Value